BIO PREVENTIVE MEDICINE CORP. Bio Preventive Medicine Corp. Stock
Equities
6810
TW0006810005
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 37.6 TWD | -0.13% |
|
-1.05% | -0.53% |
| 1 week | -1.05% | ||
| Current month | -1.31% |
| 1 day | -0.13% | ||
| 1 week | -1.05% | ||
| Current month | -1.31% | ||
| 1 month | -4.08% | ||
| 3 months | -6.23% | ||
| 6 months | -2.59% | ||
| Current year | -0.53% |
1 week
37.20
38.15
1 month
37.2040.15
Current year
35.9545.10
1 year
34.9045.10
3 years
17.2060.00
5 years
17.2060.00
10 years
17.2060.00
| Managers | Title | Age | Since |
|---|---|---|---|
Tzu Ling Tseng
CEO | Chief Executive Officer | - | 14-06-22 |
Tsu Hsun Kuo
DFI | Director of Finance/CFO | - | 22-08-10 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Fan Chuan Shih
BRD | Director/Board Member | - | 22-06-28 |
Yao Hui Wei
BRD | Director/Board Member | - | 20-12-01 |
Tzu Ling Tseng
CEO | Chief Executive Officer | - | 14-06-22 |
Bio Preventive Medicine Corp is a Taiwan-based company mainly engaged in the research, development, manufacture and sale of medical testing reagents, as well as the provision of testing services. The main products are in vitro testing reagents, which are mainly used in the early detection and prevention of diabetes complications, chronic kidney diseases and other chronic diseases, and cancers. The Company operates in North America, Europe, Asia and South America markets.
| 1st Jan change | Capi. | |
|---|---|---|
| -0.53% | 40.03M | |
| -4.52% | 12.35B | |
| -3.76% | 8.17B | |
| +6.71% | 5.77B | |
| +31.48% | 5.65B | |
| -10.28% | 4.1B | |
| +10.72% | 2.67B | |
| -61.53% | 2.57B | |
| -8.27% | 2.31B | |
| +16.56% | 2.02B |
- Stock Market
- Equities
- 6810 Stock
